Displaying 1 - 50 of 149 results
Released Company Title Industry Topic
30 Sep 2021
07:00 CEST
ACACIA PHARMA Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption 20103010 Biotechnology Other subject
29 Sep 2021
07:00 CEST
ACACIA PHARMA Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets 20103010 Biotechnology Other subject
23 Sep 2021
13:10 CEST
ACACIA PHARMA Correction: Notice of Results 20103010 Biotechnology Other subject
23 Sep 2021
13:00 CEST
ACACIA PHARMA Notice of Results 20103010 Biotechnology Other subject
16 Sep 2021
07:00 CEST
ACACIA PHARMA Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation 20103010 Biotechnology Other subject
02 Sep 2021
07:00 CEST
ACACIA PHARMA Acacia Pharma to Host Webinar with Key Opinion Leaders to Discuss the Hospital User Experience with Barhemsys® and Byfavo® 20103010 Biotechnology Other subject
05 Jul 2021
15:02 CEST
ACACIA PHARMA Correction: Transparency Notification - PDF of Notification attached 20103010 Biotechnology Other subject
01 Jul 2021
08:00 CEST
ACACIA PHARMA Transparency Notification 20103010 Biotechnology Other subject
01 Jul 2021
07:00 CEST
ACACIA PHARMA Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US 20103010 Biotechnology Other subject
29 Jun 2021
07:00 CEST
ACACIA PHARMA Results of Annual General Meeting 20103010 Biotechnology General meeting / Board Meeting
25 May 2021
18:00 CEST
ACACIA PHARMA Acacia Pharma Group plc: Notice of Annual General Meeting 20103010 Biotechnology General meeting / Board Meeting
25 May 2021
12:00 CEST
ACACIA PHARMA Acacia Pharma to Participate in Jefferies Virtual Healthcare Conference 20103010 Biotechnology Meetings / events
19 May 2021
07:00 CEST
ACACIA PHARMA Acacia Pharma Appoints Debra Hussain as Chief Commercial Officer 20103010 Biotechnology Other subject
04 May 2021
07:00 CEST
ACACIA PHARMA Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital and Reduction in Debt Service Obligations 20103010 Biotechnology Other subject
21 Apr 2021
07:00 CEST
ACACIA PHARMA Acacia Pharma Becomes New Industry Supporter of the American Society of Anesthesiologists 20103010 Biotechnology Other subject
30 Mar 2021
07:00 CEST
ACACIA PHARMA Publication of Annual Report 2020 20103010 Biotechnology Other subject
29 Mar 2021
07:00 CEST
ACACIA PHARMA Results for the year ended 31 December 2020 20103010 Biotechnology Other subject
18 Mar 2021
08:00 CET
ACACIA PHARMA Notice of Full Year 2020 Results 20103010 Biotechnology Other subject
11 Mar 2021
18:00 CET
ACACIA PHARMA Total Number of Voting Rights and Capital 20103010 Biotechnology Change in Capital
05 Mar 2021
09:05 CET
ACACIA PHARMA Transparency Notification 20103010 Biotechnology Other subject
26 Feb 2021
08:00 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
26 Feb 2021
08:00 CET
ACACIA PHARMA Transparency Notification 20103010 Biotechnology Other subject
23 Feb 2021
08:00 CET
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
19 Feb 2021
08:00 CET
ACACIA PHARMA Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities 20103010 Biotechnology Other subject
18 Feb 2021
13:15 CET
ACACIA PHARMA Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS® 20103010 Biotechnology Other subject
18 Feb 2021
09:00 CET
ACACIA PHARMA  Change of EU home Member State 20103010 Biotechnology Other subject
12 Feb 2021
07:00 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
04 Feb 2021
07:00 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
28 Jan 2021
07:00 CET
ACACIA PHARMA Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less 20103010 Biotechnology Other subject
21 Jan 2021
13:00 CET
ACACIA PHARMA Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference 20103010 Biotechnology Other subject
20 Jan 2021
11:40 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
20 Jan 2021
08:00 CET
ACACIA PHARMA Acacia Pharma wins BEL Small Company of the Year for the second consecutive year 20103010 Biotechnology Other subject
18 Dec 2020
13:45 CET
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Dec 2020
13:18 CET
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Dec 2020
13:17 CET
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Dec 2020
11:04 CET
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
17 Dec 2020
11:14 CET
ACACIA PHARMA Publication of Supplementary Prospectus 20103010 Biotechnology Other subject
15 Dec 2020
09:07 CET
ACACIA PHARMA Correction: Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ 20103010 Biotechnology Other subject
15 Dec 2020
07:46 CET
ACACIA PHARMA Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ 20103010 Biotechnology Other subject
13 Oct 2020
09:12 CEST
ACACIA PHARMA Director/PDMR Shareholding 20103010 Biotechnology Other subject
13 Oct 2020
09:10 CEST
ACACIA PHARMA Director/PDMR Shareholding 20103010 Biotechnology Other subject
13 Oct 2020
09:06 CEST
ACACIA PHARMA Issue of Shares to Employee Benefit Trust 20103010 Biotechnology Other subject
09 Oct 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™ 20103010 Biotechnology Other subject
06 Oct 2020
16:45 CEST
ACACIA PHARMA Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US 20103010 Biotechnology Other subject
24 Aug 2020
07:00 CEST
ACACIA PHARMA BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV 20103010 Biotechnology Other subject
19 Aug 2020
12:16 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
19 Aug 2020
12:14 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
19 Aug 2020
12:10 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Aug 2020
08:01 CEST
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
14 Aug 2020
13:25 CEST
ACACIA PHARMA Publication of Prospectus 20103010 Biotechnology Other subject